Fifth Third Wealth Advisors
TGTX icon

Fifth Third Wealth Advisors’s TG Therapeutics TGTX Stock Holding History

Fifth Third Wealth Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$327K Buy
5,871
+796
+16% +$43.1K 0.01% 716
2026
Q2 		$279K Buy
+5,075
New +$208K 0.01% 746

Other funds holding TGTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $45.4B AUM 34.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fifth Third Wealth Advisors's TGTX Position: Q3 2026 in Review

Fifth Third Wealth Advisors increased its TG Therapeutics (TGTX) stake by 16% in Q3 2026, buying an estimated $43.1K and bringing the position to 5,871 shares worth $327K. The position accounts for 0.01% of the portfolio, ranked #716.

Fifth Third Wealth Advisors first reported a position in TGTX in Q2 2026 and has held it in 2 quarters since. 247 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Fifth Third Wealth Advisors held 5,871 shares of TG Therapeutics worth $327K as of Q3 2026.
  • Fifth Third Wealth Advisors bought 796 TG Therapeutics shares in Q3 2026, an estimated $43.1K.
  • TG Therapeutics made up 0.01% of Fifth Third Wealth Advisors's portfolio in Q3 2026, its #716 holding.
  • Fifth Third Wealth Advisors first reported a position in TG Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 247 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.